Lone Pine Capital LLC Stephen Mandel
Greenwich, CT 20 processed 13Fs on this site, 2021 Q3 to 2026 Q2
- $16.4B
- 34 holdings
- 2026 Q2
- +30.4% QoQ
- Top 5 30.9%
AUM over time
Book
| SHOP, Shopify | Hold | 1,430,135 | $1,356 | $1.9B | |
| SNAP | Hold | 22,638,657 | $73.87 | $1.7B | |
| DASH, DoorDash | Hold | 7,460,157 | $205.98 | $1.5B | |
| BBWI, Bath & Body Works | Hold | 24,300,268 | $63.03 | $1.5B | |
| NOW, ServiceNow | Hold | 2,193,941 | $622.27 | $1.4B | |
| MSFT, Microsoft | Hold | 4,694,472 | $281.92 | $1.3B | |
| Hold | 21,533,828 | $60.39 | $1.3B | ||
| XYZ, Block | Hold | 5,380,864 | $239.84 | $1.3B | |
| MRNA, Moderna | Hold | 3,316,199 | $384.86 | $1.3B | |
| WDAY, Workday | Hold | 4,973,868 | $249.89 | $1.2B | |
| MTCH, Match Group | Hold | 7,773,867 | $156.99 | $1.2B | |
| AMZN, Amazon | Hold | 361,112 | $3,285 | $1.2B | |
| UNH, UnitedHealth Group | Hold | 3,005,990 | $390.74 | $1.2B | |
| ADBE, Adobe | Hold | 1,955,187 | $575.72 | $1.1B | |
| META, Meta Platforms | Hold | 3,074,926 | $339.39 | $1B | |
| Coupa Software | Hold | 4,566,251 | $219.18 | $1B | |
| RH | Hold | 1,290,620 | $666.91 | $861M | |
| Farfetch | Hold | 22,945,132 | $37.48 | $860M | |
| DXCM, DexCom | Hold | 1,441,227 | $546.86 | $788M | |
| IBN, Icici Bank | Hold | 39,750,227 | $18.87 | $750M | |
| DDOG, Datadog | Hold | 4,646,717 | $141.35 | $657M | |
| CVNA, Carvana | Hold | 2,142,309 | $301.54 | $646M | |
| BILI, Bilibili | Hold | 8,612,782 | $66.17 | $570M | |
| BEKE, KE Holdings | Hold | 30,201,786 | $18.26 | $551M | |
| Stoneco | Hold | 15,093,113 | $34.72 | $524M | |
| TDG, TransDigm | Hold | 784,342 | $624.57 | $490M | |
| VSXY, Victorias Secret And | Hold | 8,609,543 | $55.26 | $476M | |
| PVH, Phillips Van Heusen | Hold | 3,297,609 | $102.79 | $339M | |
| ASND, Ascendis Pharma A/s | Hold | 1,436,981 | $159.39 | $229M | |
| FATE, Fate Therapeutics | Hold | 2,199,284 | $59.27 | $130M | |
| Vtex | Hold | 5,274,887 | $20.57 | $109M | |
| FIGS, FIGS Inc | Hold | 2,485,894 | $37.14 | $92M | |
| AMPL, Amplitude | Hold | 1,627,000 | $54.34 | $88M | |
| NTES, NetEase | Hold | 1,015,388 | $85.40 | $87M | |
| Confluent | Hold | 1,394,644 | $59.65 | $83M | |
| Marqeta | Hold | 2,621,520 | $22.12 | $58M | |
| Zymeworks | Hold | 976,735 | $29.04 | $28M | |
| Forma Therapeutics | Hold | 800,000 | $23.19 | $19M | |
| Freshworks | Hold | 275,000 | $42.69 | $12M |
Filings history
20 periods, with AUM normalized
| Period | Holds | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 34 | $16.4B | +30.4% | 13F-HR | 8/14/2026 | 000091957426005485 |
| 2026 Q1 | 36 | $12.5B | −7.8% | 13F-HR | 5/15/2026 | 000091957426003439 |
| 2025 Q4 | 32 | $13.6B | −1.0% | 13F-HR | 2/17/2026 | 000090266426001084 |
| 2025 Q3 | 25 | $13.7B | −2.2% | 13F-HR | 11/14/2025 | 000090266425004988 |
| 2025 Q2 | 24 | $14.1B | +21.4% | 13F-HR | 8/14/2025 | 000090266425003627 |
| 2025 Q1 | 24 | $11.6B | −14.0% | 13F-HR | 5/15/2025 | 000090266425002417 |
| 2024 Q4 | 30 | $13.5B | +0.4% | 13F-HR | 2/14/2025 | 000090266425001072 |
| 2024 Q3 | 29 | $13.4B | +8.7% | 13F-HR | 11/14/2024 | 000090266424006633 |
| 2024 Q2 | 24 | $12.3B | −2.7% | 13F-HR | 8/14/2024 | 000090266424005150 |
| 2024 Q1 | 26 | $12.7B | +9.6% | 13F-HR | 5/15/2024 | 000090266424003638 |
| 2023 Q4 | 25 | $11.6B | +11.4% | 13F-HR | 2/14/2024 | 000090266424001732 |
| 2023 Q3 | 26 | $10.4B | −4.9% | 13F-HR | 11/14/2023 | 000090266423005548 |
| 2023 Q2 | 29 | $10.9B | +1.0% | 13F-HR | 8/14/2023 | 000090266423004451 |
| 2023 Q1 | 29 | $10.8B | +3.1% | 13F-HR | 5/15/2023 | 000090266423003075 |
| 2022 Q4 | 30 | $10.5B | −1.3% | 13F-HR | 2/14/2023 | 000090266423001763 |
| 2022 Q3 | 31 | $10.6B | 0.0% | 13F-HR | 11/14/2022 | 000090266422004869 |
| 2022 Q2 | 30 | $10.6B | −36.9% | 13F-HR | 8/15/2022 | 000090266422003974 |
| 2022 Q1 | 30 | $16.8B | −31.1% | 13F-HR | 5/16/2022 | 000156761922010934 |
| 2021 Q4 | 29 | $24.4B | −17.8% | 13F-HR | 2/14/2022 | 000156761922004367 |
| 2021 Q3 | 39 | $29.7B | — | 13F-HR | 11/15/2021 | 000090266421004961 |
About
Lone Pine Capital LLC
20 processed 13Fs on this site, 2021 Q3 to 2026 Q2